Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

Table 3 Linear regression analysis between clinicopathologic characteristics and mRNA expression count of SLC7A3, SLC7A5, and SLC7A11 genes

Clinical features	SLC7A3		SLC7A5		SLC7A11
Clinical features	t value	P value	t value	P value	t value	P value
Age	0.76	0.45	− 1.61	0.11	− 1.04	0.30
Tumor size	0.49	0.63	− 0.95	0.34	− 0.51	0.61
Gender (male)	3.18	0.00	0.93	0.35	− 1.34	0.18
Thyroiditis	−0.92	0.36	0.61	0.54	1.17	0.24
ETE	2.17	0.03	0.85	0.39	− 1.62	0.11
AJCC stage	2.69	0.01	− 1.01	0.31	− 2.06	0.04
BRAF mutation	− 1.49	0.14	0.42	0.67	− 0.92	0.36
RAS mutation	− 2.41	0.02	− 1.89	0.06	0.48	0.63
Mortality	2.39	0.02	2.02	0.04	1.65	0.10

ISSN: 1477-7819